If you need more lookups,
subscriptions start at $34 USD/month.
Jon Wigginton Location
Washington, DC, US
Jon Wigginton Work
President, Research and Development @ (August 2022 - Present)
Member, Board Of Directors @ (December 2020 - Present)
Founder and President @ Bethesda Biomedical Consulting, Inc. (April 2020 - Present)
Chairman SAB and Senior Advisor @ (May 2021 - August 2022)
Portfolio Chief Medical Officer @ (April 2020 - May 2021)
Member, Board of Directors @ (January 2022 - May 2022)
Chief Medical Officer and Senior Vice-President, Clinical Development @ (August 2013 - March 2020)
Therapeutic Area Head, Early Clinical Development, Immuno-Oncology @ (September 2010 - August 2013)
Executive Medical Director, Discovery Medicine-Clinical Oncology @ (October 2009 - August 2013)
Group Medical Director. Discovery Medicine-Clinical Oncology @ (October 2008 - October 2009)
President and Vice-President and Immediate Past-President @ (January 2004 - January 2010)
Director, Clinical Oncology @ (May 2006 - October 2008)
Head, Investigational Biologics Section @ (July 1992 - May 2007)
Jon Wigginton Education
National Cancer Institute
University of Michigan
Bachelor of Science (Biology)
University of Michigan
Doctor of Medicine (Medicine)
Jon Wigginton Skills
Angiogenesis
Antibodies
Apoptosis
BMS-936558
BMS-936559
Biologics
Biotechnology
Bispecific
Cancer
Cancer Biology
Cancer Immunotherapy
Cancer Research
Clinical Development
Clinical Research
Clinical Trial Design
Clinical Trials
Combination Therapy
Drug Development
Drug Discovery
Experimental Therapeutics
Hematology
IND
Immuno-Oncology
Immunology
In Vivo
Inflammation
Kidney Cancer
Lifesciences
Management
Medical Affairs
Melanoma
National Cancer Institute
Neuroblastoma
Oncology
PD-1
PD-L1
Pharmaceutical Industry
Phase I
Phase II
Phase III
Preclinical Models
SITC
Small Molecules
Thoracic Oncology
Translational Medicine
Translational Research
Tumor Immunology
Vaccines
Yervoy (ipilimumab) plus Anti-PD-1 (nivolumab)
Pd 1
Experimental
Strategic Planning
Bms 936558
Microsoft Office
Data Management
Yervoy Ipilimumab
National Cancer
Bms 936559
Sales
Yervoy Ipilimumab Plus Anti Pd 1 Nivolumab
Business Strategy
Pd L1
Training
Project Management
Strategy
Immuno Oncology
Public Speaking
Yervoy
Yervoy Plus Anti Pd 1
Jon Wigginton Summary
Jon Wigginton, based in Washington, DC, US, is currently a President, Research and Development at Bright Peak Therapeutics. Jon Wigginton brings experience from previous roles at Sutro Biopharma, Inc., Bethesda Biomedical Consulting, Inc. and Cullinan Oncology. Jon Wigginton holds a National Cancer Institute. With a robust skill set that includes Angiogenesis, Antibodies, Apoptosis, BMS-936558, BMS-936559 and more. Jon Wigginton has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jon Wigginton?
Find contact details for 700 million professionals.